美国安进地舒单抗注射液的最新价格

It is a monoclonal antibody that specifically targets receptor activator of nuclear factor kappa B ligand (RANKL). It can inhibit the activation and development of osteoclasts, reduce bone resorption, and increase bone density. It is used for the treatment of osteoporosis in postmenopausal women and has good safety and effectiveness. The U.S. Food and Drug Administration (FDA) approved denosumab for the prevention and treatment of bone-related symptoms in patients with bone metastases from solid tumors and adult and skeletally mature adolescent patients with giant osteocytoma that cannot be surgically removed or that may result in severe comorbidities.

On May 27, 2019, denosumab was approved by the FDA for sale in China, which means that patients can purchase denosumab in pharmacies in China. But it is a pity that denosumab has not yet been included in the national medical insurance, so it cannot bring certain medical insurance benefits to patients. Whether at home or abroad, the price of denosumab is relatively expensive. The price of denosumab 120mg produced by Amgen in the United States is about $3,000, which puts a certain amount of pressure on patients.

What is the latest price of Amgen injection in the United States? As one of the world's largest biopharmaceutical companies, Amgen is a leader in the global biopharmaceutical industry. It has strong R&D capabilities and product advantages. It insists on developing in the field of biotechnology for disease treatment. Its main fields include human genome, cancer, neuroscience and small molecule chemistry. According to Medical Companion Travel, Amgen’s denosumab in the United States is currently available in 120 mg and the price is only $1,450, which is more suitable for long-term use by patients. Since the exchange rate has been fluctuating for a long time and the price is unstable, please contact Medical Travel for details.